blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2975135

EP2975135 - Glycopegylated factor IX [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  16.03.2018
Database last updated on 11.04.2026
FormerExamination is in progress
Status updated on  31.03.2017
FormerRequest for examination was made
Status updated on  16.12.2016
Most recent event   Tooltip16.03.2018Withdrawal of applicationpublished on 18.04.2018  [2018/16]
Applicant(s)For all designated states
Novo Nordisk A/S
Corporate Patents Novo Allé
2880 Bagsværd / DK
[2016/03]
Inventor(s)01 / Bayer, Robert J.
6105 Dirac Street
San Diego, CA 92122 / US
02 / Panneerselvam, Krishnasamy
14917 Morningside Dr.
Poway, CA 92064 / US
03 / Defrees, Shawn
126 Filly Drive
North Wales, PA 19454 / US
04 / Bowe, Caryn
310 Maple Avenue
Doylestown, PA 18901 / US
 [2016/03]
Application number, filing date15151467.625.05.2006
[2016/03]
Priority number, dateUS20050684729P25.05.2005         Original published format: US 684729 P
US20050707994P12.08.2005         Original published format: US 707994 P
US20050710535P23.08.2005         Original published format: US 710535 P
[2016/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2975135
Date:20.01.2016
Language:EN
[2016/03]
Search report(s)(Supplementary) European search report - dispatched on:EP21.10.2015
ClassificationIPC:C12Q1/56, A61K47/48, C12N9/64
[2016/03]
CPC:
A61K38/4846 (EP,US); A61K47/549 (EP,US); A61K47/60 (EP,US);
A61P7/04 (EP); C12N9/644 (EP,US); C12Y304/21022 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/35]
Former [2016/03]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Glykopegylierter Faktor IX[2016/03]
English:Glycopegylated factor IX[2016/03]
French:Facteur IX glycopégylé[2016/03]
Examination procedure24.06.2015Loss of particular rights, legal effect: Claims
01.07.2015Despatch of communication of loss of particular rights: Claims {1}
19.07.2016Amendment by applicant (claims and/or description)
20.07.2016Examination requested  [2016/35]
31.03.2017Despatch of a communication from the examining division (Time limit: M06)
08.11.2017Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
18.01.2018Reply to a communication from the examining division
14.03.2018Application withdrawn by applicant  [2018/16]
Parent application(s)   TooltipEP06784467.0  / EP1891231
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
18.01.2018Request for further processing filed
18.01.2018Full payment received (date of receipt of payment)
Request granted
31.01.2018Decision despatched
Fees paidRenewal fee
18.05.2015Renewal fee patent year 03
18.05.2015Renewal fee patent year 04
18.05.2015Renewal fee patent year 05
18.05.2015Renewal fee patent year 06
18.05.2015Renewal fee patent year 07
18.05.2015Renewal fee patent year 08
18.05.2015Renewal fee patent year 09
01.06.2015Renewal fee patent year 10
31.05.2016Renewal fee patent year 11
31.05.2017Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XP] WO2005055950  (NEOSE TECHNOLOGIES INC et al.)
 [Y] US2005058620  (NAKAMOTO KEN-ICHIRO et al.)
 [Y] WO9621469  (SHEARWATER POLYMERS INC et al.)
 [Y] WO2004083258  (NEOSE TECHNOLOGIES INC et al.)
 [Y] WO2004091499  (NEOSE TECHNOLOGIES INC et al.)
 [XY] WO03031464  (NEOSE TECHNOLOGIES INC et al.)
 [XY] US2004063911  (DEFREES SHAWN et al.)
 [YP]   DEFREES S ET AL: "GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli", GLYCOBIOLOGY, OXFORD UNIVERSITY PRESS, US, vol. 16, no. 9, 22 May 2006 (2006-05-22), pages 833 - 843, XP002403450, ISSN: 0959-6658, DOI: 10.1093/GLYCOB/CWL004

DOI:   http://dx.doi.org/10.1093/glycob/cwl004
 [A]   MILTON HARRIS J ET AL: "EFFECT OF PEGYLATION ON PHARMACEUTICALS", NATURE REVIEWS. DRUG DISCOVERY, NATURE PUBLISHING GROUP, GB, vol. 2, no. 3, 1 March 2003 (2003-03-01), pages 214 - 221, XP009042217, ISSN: 1474-1784, DOI: 10.1038/NRD1033

DOI:   http://dx.doi.org/10.1038/nrd1033
 [A]   SHINJI YOSHITAKE ET AL: "Nucleotide Sequence of the Gene for Human Factor IX (Antihemophilic Factor B)", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 24, no. 14, 1 July 1985 (1985-07-01), pages 3736 - 3750, XP001318488, ISSN: 0006-2960
 [A]   AMY D SHAPIRO ET AL: "The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 105, no. 2, 15 January 2005 (2005-01-15), pages 518 - 525, XP008125078, ISSN: 0006-2960
by applicantUS4179337
 US4088538
 US4496689
 US4414147
 US4055635
 WO8700056
 WO9405332
 US6399336
 US2003040037
 US2004132640
 US2004137557
 US2004126838
 US2004142856
 WO9216640
 US5932462
 US5629384
 US4770999
 US5521070
 US6037452
 US6046380
 US2005002522
 WO9417039
 US5324844
 WO9418247
 WO9404193
 US5219564
 US5122614
 WO9013540
 US5281698
 WO9315189
 WO9415625
 WO9409027
 US4412989
 US5672662
 US6376604
 WO9945964
 WO9621469
 US5446090
 WO9934833
 WO9914259
 US6348558
 US5342940
 US5643575
 US5919455
 US6113906
 US5183660
 WO0209766
 US4826945
 US4438253
 US5202413
 US5410016
 US5529914
 US4522811
 US28799402
 US5605793
 US5837458
 US5830721
 US5811238
 WO9831826
 US5876980
 US6030815
 US5728554
 US5922577
 WO8705330
 US4806595
 WO9218135
 WO9632491
 US5352670
 US5374541
 US5545553
 US5716812
   NELSESTUEN, VITAM. HORM., vol. 58, 2000, pages 355 - 389
   MANFIOLETTI ET AL., MOL. CELL. BIOL., vol. 13, 1993, pages 4976 - 4985
   LUO ET AL., NATURE, vol. 386, 1997, pages 78 - 81
   SORENSEN ET AL., J. BIOL. CHEM., vol. 272, 1997, pages 11863 - 11868
   HEDNER ET AL., TRANSFUS. MED. REV., vol. 7, 1993, pages 78 - 83
   YAMAMOTO ET AL., CARBOHYDR. RES., vol. 305, 1998, pages 415 - 422
   SAMBROOK ET AL.: "MOLECULAR CLONING: A LABORATORY MANUAL", 1989, COLD SPRING HARBOR LABORATORY PRESS
   VARKI ET AL.: "Essentials of Glycobiology", 1999, CSHL PRESS
   NADANO ET AL., J. BIOL. CHEM., vol. 261, 1986, pages 11550 - 11557
   KANAMORI ET AL., J. BIOL. CHEM., vol. 265, 1990, pages 21811 - 21819
   VARKI, GLYCOBIOLOGY, vol. 2, 1992, pages 25 - 40
   R. SCHAUER: "Sialic Acids: Chemistry, Metabolism and Function", 1992, SPRINGER-VERLAG
   B. WEINSTEIN: "CHEMISTRY AND BIOCHEMISTRY OF AMINO ACIDS, PEPTIDES AND PROTEINS", 1983, MARCEL DEKKER, article SPATOLA, A. F., pages: 267
   DFA CROMMELIN AND RD SINDELAR: "Pharmaceutical Biotechnology", 1997, HARWOOD PUBLISHERS, pages: 101 - 120
   LEE ET AL., HEMOPHILIA, vol. 12, no. 3, 2006, pages 1 - 7
   BIGGS: "Human Blood Coagulation Haemostasis and Thrombosis", 1972, BLACKWELL, SCIENTIFIC, pages: 614
   PROCTOR; RAPAPORT, AMER. J. CLIN. PATH., vol. 36, 1961, pages 212
   VERONES, APP. BIOCHEM. BIOTECH., vol. 11, 1985, pages 141 - 45
   HARRIS, MACRONOL. CHEM. PHYS., vol. C25, 1985, pages 325 - 373
   SCOUTEN, METHODS IN ENZYMOLOGY, vol. 135, 1987, pages 30 - 65
   WONG ET AL., ENZYME MICROB. TECHNOL., vol. 14, 1992, pages 866 - 874
   DELGAD ET AL., CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, vol. 9, 1992, pages 249 - 304
   ZALIPSKY, BIOCONJUGATE CHEM., vol. 6, 1995, pages 150 - 165
   BHADRA ET AL., PHARMAZIE, vol. 57, 2002, pages 5 - 29
   KODERA Y., BIOCONJUGATE CHEMISTRY, vol. 5, 1994, pages 283 - 288
   YAMASAKI ET AL., AGRIC. BIOL. CHEM., vol. 52, 1998, pages 2125 - 2127
   DUNN ET AL.: "POLYMERIC DRUGS AND DRUG DELIVERY SYSTEMS", vol. 469, 1991, AMERICAN CHEMICAL SOCIETY
   YOUNES ET AL., JBIOMED. MATER. RES., vol. 21, 1987, pages 1301 - 1316
   COHN ET AL., JBIOMED. MATER. RES., vol. 22, 1988, pages 993 - 1009
   SAWHNEY ET AL., MACROMOLECULES, vol. 26, 1993, pages 581 - 587
   CHRISEY ET AL., NUCLEIC ACIDS RES., vol. 24, 1996, pages 3031 - 3039
   STEMMER, PROC. NATL. ACAD. SCI. USA, vol. 91, 1994, pages 10747 - 10751
   STEMMER, NATURE, vol. 370, 1994, pages 389 - 391
   HAKIMUDDIN ET AL., ARCH. BIOCHEM. BIOPHYS., vol. 259, 1987, pages 52
   EDGE ET AL., ANAL. BIOCHEM., vol. 118, 1981, pages 131
   THOTAKURA ET AL., METH. ENZYMOL., vol. 138, 1987, pages 350
   APLIN; WRISTON, CRC CRIT. REV. B ., 1981, pages 259 - 306
   ABUCHOWSKI ET AL., CANCER BIOCHEM. BIOPHYS.,, vol. 7, 1984, pages 175 - 186
   ABUCHOWSKI ET AL., J. BIOL. CHEM., vol. 252, 1977, pages 3582 - 3586
   JACKSON ET AL., ANAL. BIOCHEM., vol. 165, 1987, pages 114 - 127
   KOIDE ET AL., BIOCHEM BIOPHYS. RES. COMMUN., vol. 111, 1983, pages 659 - 667
   NILSSON ET AL., METHODS ENZYMOL., vol. 104, 1984, pages 56 - 69
   DELGADO ET AL., BIOTECHNOL. APPL. BIOCHEM., vol. 12, 1990, pages 119 - 128
   BUCKMANN ET AL., MAKROMOL. CHEM., vol. 182, 1981, pages 1379 - 1384
   JOPPICH ET AL., MAKROMOL. CHEM., vol. 180, 1979, pages 1381 - 1384
   ABUCHOWSK ET AL., CANCER BIOCHEM. BIOPHYS., vol. 7, 1984, pages 175 - 186
   KATRE ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 84, 1987, pages 1487 - 1491
   KITAMURA ET AL., CANCER RES., vol. 51, 1991, pages 4310 - 4315
   BOCCU ET AL., Z. NATURFORSCH., vol. 38C, 1983, pages 94 - 99
   HARRIS: "POLY(ETHYLENE GLYCOL) CHEMISTRY: BIOTECHNICAL AND BIOMEDICAL APPLICATIONS", 1992, PLENUM PRESS, article ZALIPSKY ET AL., pages: 347 - 370
   ZALIPSKY ET AL., BIOTECHNOL. APPL. BIOCHEM., vol. 15, 1992, pages 100 - 114
   VERONESE ET AL., APPL. BIOCHEM. BIOTECH., vol. 11, 1985, pages 141 - 152
   BEAUCHAMP ET AL., ANAL. BIOCHEM., vol. 131, 1983, pages 25 - 33
   BERG ET AL., BLOOD, vol. 71, 1988, pages 1641 - 1647
   WOGHIREN ET AL., BIOCONJUGATE CHEM., vol. 4, 1993, pages 314 - 318
   BYUN ET AL., ASAIO JOURNAL, 1992, pages M649 - M-653
   VERONESE ET AL., APPL. BIOCHEM. BIOTECHNOL.,, vol. 11, 1985, pages 141 - 152
   MICHAEL, DIELS-ALDER ADDITION
   MARCH: "ADVANCED ORGANIC CHEMISTRY, 3rd ed.", 1985, JOHN WILEY & SONS
   HERMANSON: "BIOCONJUGATE TECHNIQUES", 1996, ACADEMIC PRESS
   FEENEY ET AL.: "Advances in Chemistry Series", vol. 198, 1982, AMERICAN CHEMICAL SOCIETY, article "MODIFICATION OF PROTEINS"
   GREENE ET AL.: "PROTECTIVE GROUPS IN ORGANIC SYNTHESIS", 1991, JOHN WILEY & SONS
   ELHALABI ET AL., CURR. MED. CHEM., vol. 6, 1999, pages 93
   SCHAFER ET AL., J. ORG. CHEM., vol. 65, 2000, pages 24
   KEPPLER ET AL., GLYCOBIOLOGY, vol. 11, 2001, pages 11R
   CHARTE ET AL., GLYCOBIOLOGY, vol. 10, 2000, pages 1049
   J. MILTON HARRIS: "POLY (ETHYLENE G LYCOL ) CHEMICAL AND BIOLOGICAL APPLICATIONS", 1997, AMERICAN CHEMICAL SOCIETY
   LEE ET AL., BIOCHEMISTRY, vol. 28, 1989, pages 1856
   BHATIA ET AL., ANAL. BIOCHEM., vol. 178, 1989, pages 408
   JANDA ET AL., J. AM. CHEM. SOC., vol. 112, 1990, pages 8886
   WOLD, F., METH. ENZYMOL., vol. 25, 1972, pages 623 - 651
   HOLCENBERG, AND ROBERTS: "ENZYMES AS DRUGS", 1981, WILEY, article WEETALL, H. H.; COONEY, D. A., pages: 395 - 442
   JI, T. H., METH. ENZYMOL., vol. 91, 1983, pages 580 - 609
   MATTSON ET AL., MOL. BIOL. REP., vol. 17, 1993, pages 167 - 183
   JUNG ET AL., BIOCHEM. BIOPHYS. ACTA, vol. 761, 1983, pages 152 - 162
   JOSHI ET AL., J. BIOL. CHEM., vol. 265, 1990, pages 14518 - 14525
   ZARLING E, J. IMMUNOL., vol. 124, 1980, pages 913 - 920
   BOUIZAR ET AL., EUR. J. BIOCHEM., vol. 155, 1986, pages 141 - 147
   PARK ET AL., J. BIOL. CHEM., vol. 261, 1986, pages 205 - 210
   BROWNING ET AL., J. IMMUNOL., vol. 143, 1989, pages 1859 - 1867
   SHE ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., vol. 102, 1991, pages 1048
   ITO ET AL., PURE APPL. CHEM., vol. 65, 1993, pages 753
   PAULSON ET AL., J. BIOL. CHEM., vol. 253, 1978, pages 5617 - 5624
   URDAL ET AL., J. CHROMATOG., vol. 296, 1984, pages 171
   LIN ET AL., BLOOD, 1997
   EWENSTEIN ET AL., TRANSFUSION, 2002
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.